Latest Insider Transactions at Organicell Regenerative Medicine, Inc. (OCEL)
This section provides a real-time view of insider transactions for Organicell Regenerative Medicine, Inc. (OCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organicell Regenerative Medicine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organicell Regenerative Medicine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,289
+2.44%
|
$14,578
$2.75 P/Share
|
|
Nov 19
2024
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,000
+1.73%
|
$10,000
$2.65 P/Share
|
|
Nov 18
2024
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+3.47%
|
$20,000
$2.59 P/Share
|
|
Sep 03
2024
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
9,000
+3.24%
|
$18,000
$2.2 P/Share
|
|
Aug 30
2024
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+0.38%
|
$2,000
$2.2 P/Share
|
|
Apr 01
2024
|
Steven Jerry Glauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+32.61%
|
-
|
|
Apr 01
2024
|
Leathem S Stearn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+33.33%
|
-
|
|
Dec 19
2023
|
Harry L. Leider Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,248
-100.0%
|
$5,248
$1.31 P/Share
|
|
Jul 07
2023
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
320,710
+0.62%
|
$0
$0.01 P/Share
|
|
Jun 29
2023
|
Harry L. Leider Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
500,000
+32.27%
|
$0
$0.01 P/Share
|
|
Jun 29
2023
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+0.39%
|
$0
$0.01 P/Share
|
|
Jun 28
2023
|
Harry L. Leider Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
549,450
+50.0%
|
$0
$0.1 P/Share
|
|
Jun 28
2023
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400,000
+0.78%
|
$0
$0.01 P/Share
|
|
Jun 26
2023
|
Skycrest Holdings, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
800,000
+1.55%
|
$0
$0.01 P/Share
|
|
Oct 31
2022
|
Matthew Phillip Sinnreich President and Acting CEO |
SELL
Other acquisition or disposition
|
Indirect |
6,979
-100.0%
|
-
|
|
Oct 13
2022
|
Matthew Phillip Sinnreich President and Acting CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-0.29%
|
$0
$0.04 P/Share
|
|
Oct 29
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Other acquisition or disposition
|
Direct |
15,000,000
+9.2%
|
-
|
|
Oct 29
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Other acquisition or disposition
|
Direct |
15,000,000
-10.13%
|
-
|
|
Oct 29
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
5,000,000
+5.84%
|
-
|
|
Oct 29
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Other acquisition or disposition
|
Direct |
5,000,000
-6.2%
|
-
|
|
Oct 29
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Other acquisition or disposition
|
Direct |
15,000,000
+11.39%
|
-
|
|
Oct 29
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Other acquisition or disposition
|
Direct |
15,000,000
-12.85%
|
-
|
|
Oct 29
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
15,000,000
+8.25%
|
-
|
|
Oct 29
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
15,000,000
-8.99%
|
-
|
|
Jun 17
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 17
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 17
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.02%
|
$0
$0.14 P/Share
|
|
Jun 17
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,955
-0.01%
|
$0
$0.14 P/Share
|
|
Jun 16
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.16 P/Share
|
|
Jun 16
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.16 P/Share
|
|
Jun 16
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.16 P/Share
|
|
Jun 16
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
61,454
-0.04%
|
$0
$0.15 P/Share
|
|
Jun 15
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.16 P/Share
|
|
Jun 15
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.16 P/Share
|
|
Jun 15
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.16 P/Share
|
|
Jun 15
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.16 P/Share
|
|
Jun 14
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.01%
|
$0
$0.14 P/Share
|
|
Jun 14
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 14
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.14 P/Share
|
|
Jun 14
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
32,000
-0.04%
|
$0
$0.14 P/Share
|
|
Jun 11
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.14 P/Share
|
|
Jun 11
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.02%
|
$0
$0.14 P/Share
|
|
Jun 11
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 11
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
49,910
-0.02%
|
$0
$0.14 P/Share
|
|
Jun 10
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.14 P/Share
|
|
Jun 10
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
150,000
-0.05%
|
$0
$0.14 P/Share
|
|
Jun 10
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
150,000
-0.04%
|
$0
$0.14 P/Share
|
|
Jun 10
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
85,200
-0.04%
|
$0
$0.14 P/Share
|
|
Jun 09
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.16 P/Share
|
|
Jun 09
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
80,000
-0.03%
|
$0
$0.15 P/Share
|